Therapeutics based on small molecule inhibitors
Small molecule inhibitors that block accumulation of ALS-associated RNA-binding proteins (RBPs) such as TDP-43 from accumulating in stress granules in the brain of ALS/FTD patients (Neuron Volume 103, Issue 5, 4 September 2019, Pages 802-819).